Wei H, Liu H, Chen Y, Xue X, Weng H, Ding H

Language: English
References: 12
Page: 759-764
PDF size: 212.24 Kb.

ABSTRACT

Aim. To evaluate the diagnostic value of dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) in the differential diagnosis of hepatic angiomyolipoma (HAML) and hepatocellular carcinoma (HCC) and to clarify the relationship between histopathological features and CT or MRI imaging performances in HAML. Material and methods. Six HAML and 33 non-cirrhotic HCC patients confirmed by histopathology were retrospectively analyzed. The serum biomarkers, CT and MRI examinations were conventionally performed before the confirmatory histological diagnosis. The clinical data from their medical records was also analyzed. Results. Six HAML patients were annotated as two types according to CT and MRI imaging characteristics, including hypovascular type (n = 1) and hypervascular type (n = 5). The imaging performances of the 33 HCC patients were hypervascular type. Moreover, all the 5 hypervascular type HAML patients were misdiagnosed as HCC by CT or MRI. We also found that the hypervascular type of HAML patients contained more vessels and less fatty tissues in histopathology than hypovascular type of HAML patients. However, the clinical features included HCC high risk factors (hepatitis B or C), non-specific symptoms, male and increased serum alpha fetoprotein (AFP) were more common in HCC patients than HAML patients (P ‹ 0.05, respectively). Conclusions. The CT or MRI imaging performances of HAML patients containing more vessels and less fatty tissues in histopathology resemble the imaging performance of HCC patients. These clinical features may be of great help in the differential diagnosis in the current clinical practices.

REFERENCES

1. Kamimura K, Nomoto M, Aoyagi Y. Hepatic angiomyolipoma: diagnostic findings and management. Int J Hepatol 2012; 2012: 410781.

2. Marrero JA, Ahn J, Rajender Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 2014; 109: 1328-47.

3. Rao PN. Nodule in Liver: Investigations, Differential Diagnosis and Follow-up. J Clin Exp Hepatol 2014; 4: S57-S62.

4. Wang SY, Kuai XP, Meng XX, Jia NY, Dong H. Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma. Abdom Imaging 2014; 39: 323-33.

5. Li JJ, Zheng JS, Cui SC, Cui XW, Hu CX, Fang D, Ye LC. Carm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma. World J Gastroenterol 2015; 21: 3035-40.

6. Yang X, Li A, Wu M. Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases. Med Oncol 2013; 30: 416.

7. Chang Z, Zhang JM, Ying JQ, Ge YP. Characteristics and treatment strategy of hepatic angiomyolipoma: a series of 94 patients collected from four institutions. J Gastrointestin Liver Dis 2011; 20: 65-9.

8. Kim R, Lee JM, Joo I, Lee DH, Woo S, Han JK, Choi BI. Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Abdom Imaging 2015; 40: 531-41.

9. Li R, Tang CL, Zhang Y, Ma KS, Zhang XH, Guo DY, Yan XC. Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound-A Prospective Study in Non-Cirrhotic Patients. PLoS One 2015; 10: e0132290.

10. Cai PQ, Wu YP, Xie CM, Zhang WD, Han R, Wu PH. Hepatic angiomyolipoma: CT and MR imaging findings with clinicalpathologic comparison. Abdom Imaging 2013; 38: 482-9.

11. Murakami T, Tsurusaki M. Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis. Liver Cancer 2014; 3: 85-96.

12. Tekath M, Klotz T, Montoriol PF, Joubert-Zakeyh J, Garcier JM, Da Ines D. Fat-containing lesions of the liver: a pictorial essay. Diagn Interv Imaging 2015; 96: 201-11.